Therapy Areas: AIDS & HIV
12 October 2021 - US pharmaceutical company Johnson & Johnson Inc (NYSE:JNJ) announced that Paul Stoffels, the company's chief scientific officer, will retire at the end of 2021, Reuters news...
5 October 2021 - - The first patient has been dosed with SAB-185 in the Phase 3 ACTIV-2 COVID-19 trial, US-based biopharmaceutical company SAB Biotherapeutics said.

SAB-185 is a fully hum...
5 October 2021 - Biopharmaceutical company SAB Biotherapeutics (SAB) said on Monday that it has dosed the first patient with SAB-185 in the Phase 3 ACTIV-2 COVID-19 trial led by the National Institute...
4 October 2021 - HIV/AIDS care provider AIDS Healthcare Foundation (AHF) on Friday announced a new team of international experts to restart the inquiry into the origins of COVID-19.The first internati...
28 September 2021 - - UK-based specialist HIV company ViiV Healthcare, which is majority owned by UK-based GlaxoSmithKline (NYSE: GSK), with US-based Pfizer (NYSE: PFE) and Japan-based Shionogi (OTC: ...
27 September 2021 - US pharmaceutical company Pfizer Inc (NYSE:PFE) has commenced a mid-to-late-stage study testing its investigational oral antiviral drug, PF-07321332, for the prevention of COVID-19...
Related Headlines